Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP526593.RAdlIXsexNbl0uWqwfB2EPiWocPjgktiMX-SaKeCyDw2M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP526593.RAdlIXsexNbl0uWqwfB2EPiWocPjgktiMX-SaKeCyDw2M130_assertion type Assertion NP526593.RAdlIXsexNbl0uWqwfB2EPiWocPjgktiMX-SaKeCyDw2M130_head.
- NP526593.RAdlIXsexNbl0uWqwfB2EPiWocPjgktiMX-SaKeCyDw2M130_assertion description "[Reduced vasorelaxations were associated with increased number of clinical risk factors for atherosclerosis (r = - 0.54, P < 0.001), whereas the Glu298Asp variant was not associated with any differences in contractions to phenylephrine, NO-mediated vasorelaxations to acetylcholine, bradykinin or calcium ionophore, or relaxations to the NO donor sodium nitroprusside.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526593.RAdlIXsexNbl0uWqwfB2EPiWocPjgktiMX-SaKeCyDw2M130_provenance.
- NP526593.RAdlIXsexNbl0uWqwfB2EPiWocPjgktiMX-SaKeCyDw2M130_assertion evidence source_evidence_literature NP526593.RAdlIXsexNbl0uWqwfB2EPiWocPjgktiMX-SaKeCyDw2M130_provenance.
- NP526593.RAdlIXsexNbl0uWqwfB2EPiWocPjgktiMX-SaKeCyDw2M130_assertion SIO_000772 11298374 NP526593.RAdlIXsexNbl0uWqwfB2EPiWocPjgktiMX-SaKeCyDw2M130_provenance.
- NP526593.RAdlIXsexNbl0uWqwfB2EPiWocPjgktiMX-SaKeCyDw2M130_assertion wasDerivedFrom befree-20150227 NP526593.RAdlIXsexNbl0uWqwfB2EPiWocPjgktiMX-SaKeCyDw2M130_provenance.
- NP526593.RAdlIXsexNbl0uWqwfB2EPiWocPjgktiMX-SaKeCyDw2M130_assertion wasGeneratedBy ECO_0000203 NP526593.RAdlIXsexNbl0uWqwfB2EPiWocPjgktiMX-SaKeCyDw2M130_provenance.